Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.
Cofense provides phishing threat management and remediation solutions to the world's leading brands and organizations.
Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders.
EverlyWell is a digital health company that offers consumer testing, virtual care, at-home collection tests, and digital results.
A leading provider of local locksmith services across 50 states and America’s #1 provider of key duplication kiosks.
Coupang is an e-commerce platform that offers a wide variety of products, including apparel, electronics, and home goods.
Symphony Communication Services Holdings is a messaging platform that offers a range of communication products, and real-time data services.
Sigilon Therapeutics is a biotech company that specializes in creating immune-privileged products for treating acute and chronic diseases.
Decibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair, and restore hearing.
LianBio aims to develop and accelerate availability of paradigm-shifting medicines to patients in China.
Postmates is an on-demand food delivery platform that gives customers access to restaurants and retailers.
BlackRock has invested in 323 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BlackRock's top investment sectors include Biotechnology, Health Care, Therapeutics, Enterprise Software, Software. The firm invests across 35 different industry categories.
Among tracked funding rounds, LianBio received $310.0M in a Series A round. BlackRock's total known invested capital is $104.3B.
BlackRock's average investment size is $383.3M across its portfolio of 323 companies.
Recent BlackRock portfolio additions include Vividion Therapeutics, Cofense, Design Therapeutics, EverlyWell, KeyMe Locksmiths. These companies were founded in 2020 or later.